Gut bacteria may hold key to better nutrition for cancer patients
NCT ID NCT07260617
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the bacteria in the gut and mouth relate to nutrition in 150 adults with digestive cancer starting chemotherapy. Researchers will collect stool and saliva samples, along with questionnaires and tests, before and after the first chemo cycle. The goal is to find bacterial patterns linked to malnutrition, which could lead to new ways to support patients' nutrition during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could identify gut bacteria as targets to improve nutrition and quality of life for cancer patients on chemotherapy.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not find clear links, and any potential therapies would need years of additional testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE OR LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Croix Rousse Hospital Hepatology and Gastroenterology Department
Lyon, 69004, France
-
Edouard Herriot Hospital - medical oncology department
Lyon, 69003, France
-
Lyon Sud Hospital - Hepatology and Gastroenterology Department
Lyon, 69310, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Tailored chemo doses aim to cut severe side effects in digestive cancer patients
- New drug cocktail shows promise for tough bile duct cancer
- Steroid shot during surgery may cut cancer recovery risks
- New Antibody-Drug combo targets Hard-to-Treat digestive cancers